Article Details
Retrieved on: 2024-05-13 14:02:11
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article announces Humacyte, led by Laura Niklason, attending conferences to present their regenerative medicine advancements. Their tissue engineering technology aims to revolutionize transplantation medicine, with products like HAVs already receiving RMAT designation.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here